Yee Hop : APPOINTMENT OF NON-EXECUTIVE DIRECTOR

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

YEE HOP

Yee Hop Holdings Limited

義合控股有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1662)

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

The board of directors (the "Board") of Yee Hop Holdings Limited (the "Company") is pleased to announce that Mr. Wang Jian (汪建) ("Mr. Wang") has been appointed as a non- Executive Director (the "Non-ExecutiveDirector") of the Company with effect from 19 April 2021.

Mr. Wang, aged 67, is a famous scientist specialising in human genomics and has over 30 years of experience in genomics research which covers human genomics, animal and plant genomics and microbiology. Mr. Wang graduated from Hunan Medical College (湖南醫學院) (currently known as "Central South University Xiangya School of Medicine* (中南大學湘雅 醫學院)") in 1979 and earned a Master degree in Integrated Medicines from Beijing College

of Traditional Chinese Medicine* (北京中醫學院) (currently known as "Beijing University of Chinese Medicine* (北京中醫葯大學)") in 1986. From 1988 to 1994, Mr. Wang continued his

studies at overseas focusing on cell proliferation and differentiation as a research fellowship at the University of Texas, the University of Iowa and the University of Washington.

Mr. Wang served as the deputy director of the Beijing Institute of Genomics, Chinese Academy of Sciences (中國科學院北京基因組研究所) from 2003 to 2007. He also has served

as the decision-maker and leader for research and application projects at BGI-Research* (深 圳華大基因研究院) (currently known as "BGI Life Science Research Institution* (深圳華 大生命科學研究院)") ("BGI Research"), leading a group of experts to make a number of remarkable achievements, including the Chinese Genome Map (中國人基因組圖譜) and International 1000 Genomes Project (國際千人基因組計畫亞洲部份).

Mr. Wang currently served as the chairman of BGI Genomics Co., Ltd. (深圳華大基因股份有

限公司) ("BGI Genomics") (a company listed in the Shenzhen Stock Exchange, stock code: 300676), the chairman and general manager of BGI Shenzhen (深圳華大基因科技有限公

司) ("BGI Shenzhen") (a company incorporated in the PRC and the holding company of BGI Genomics); and the chairman of MGI Tech Co., Ltd (深圳華大智造科技股份有限公司) (a

company incorporated in the People's Republic of China).

- 1 -

The Group had entered into a non-legally binding strategic cooperation framework agreement (the "Framework Agreement") with BGI Research on 7 September 2020, in relation to establishing a long-term strategic partnership to foster marine technology innovation and industry development with the use of genetic technology. Please refer to the announcement of the Company dated 7 September 2020 for details of the Framework Agreement.

BGI Research is an institution under BGI Shenzhen and as of the date of this announcement, the Group and BGI Research have not entered into any agreement in respect of any specific cooperation project. In the event that any transaction contemplated under the Framework Agreement constitutes a notifiable and/or connected transactions of the Company under the Rules Governing the Listing of Securities of the Stock Exchange of Hong Kong Limited (the "Listing Rules"), the Company will make further announcements as appropriate in compliance with the Listing Rules.

Pursuant to an appointment letter made between the Company and Mr. Wang, Mr. Wang has been appointed as a Non-Executive Director of the Company commencing from 19 April 2021. Mr. Wang is appointed for an initial term of 3 years and is subject to re-election at the next following annual general meeting of the Company after his appointment and thereafter subject to retirement by rotation and re-election in accordance with the Articles of Association of the Company and the Listing Rules. Mr. Wang shall not be entitled to any remuneration from the Company for serving as a Non-Executive Director.

Save as disclosed in this announcement:

1. Mr. Wang did not hold any directorship in any other public companies the securities of which are listed on any securities market in Hong Kong or overseas in the last three years;
2. as at the date of this announcement, Mr. Wang had a long position in 20,000,000 shares of the Company, representing approximately 4.0% of the total issued shares of the Company, as a beneficial owner within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong);
3. Mr. Wang (1) does not hold any other position in the Company or its subsidiaries; and
4. 1. does not have any relationship with any directors, senior management, substantial shareholders or controlling shareholders of the Company (as defined under the Listing Rules); and
5. Mr. Wang confirmed that saved as disclosed herein, as at the date of this announcement, there is no other information in relation to the appointment of Mr. Wang that is required to be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Listing Rules or any matters that need to be brought to the attention of the shareholders of the Company.

- 2 -

The Board would like to take this opportunity to welcome Mr. Wang to join the Company.

Certain English translations of Chinese names or words marked with "*" in this announcement are included for information purpose only and should not be regarded as the official English translation of such Chinese names or words. If there is any inconsistency between the Chinese names of entities and their English translations, the Chinese names shall prevail.

By Order of the Board of

Yee Hop Holdings Limited

Jim Yin Kwan Jackin

Chairman and Executive Director

Hong Kong, 19 April 2021

As at the date of this announcement, the Executive Directors of the Company are, Mr. Chui Mo Ming, Mr. Leung Hung Kwong Derrick, Mr. Jim Yin Kwan Jackin, Mr. Yan Chi Tat and Mr. Xu JunMin; the Non-Executive Director is Mr. Wang Jian; and the Independent Non- Executive Directors are Mr. Lee Luk Shiu, Mr. Wong Chi Keung Johnny and Mr. Yu Hon Kwan.

- 3 -